Skip to main content

Table 1 Characteristics of the subjects and laboratory parameters at the time of the trial performance

From: Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden

Parameter

Controls (N = 25)

Patients (N = 41)

p

Age (years)

42.2 (4.9)

44.8 (5.4)

ns

BMI (kg/m2)

25.4 (3.4)

27.3 (2.7)

0.02

Waist-hip ratio (rel.)

0.93 (0.04)

0.94 (0.05)

ns

Systolic blood pressure (mmHg)

133 (13)

125 (14)

0.02

Diastolic blood pressure (mmHg)

87 (11)

82 (10)

ns

Total cholesterol (mmol/l)

4.99 (0.78)

4.55 (1.0)

ns

LDL-cholesterol (mmol/l)

3.11 (0.73)

2.6 (0.87)

0.02

HDL-cholesterol (mmol/l)

1.18 (0.26)

1.02 (0.28)

0.02

TG (mmol/l)

1.50 (0.57)

2.18 (1.57)

0.04

Blood glucose (mmol/l)

5.4 (1.3)

5.9 (1.7)

ns

Smokers (N)

4 (16%)

11 (27%)

ns

Ex-smokers (N)

4 (16%)

23 (56%)

<0.01

Family history (N)

2 (8%)

14 (34%)

0.01

  1. Values are shown as means and standard deviations; p-for the difference between the two groups, ns-not significant, N-number, BMI-body mass index, rel.-relative, LDL-low density cholesterol, HDL-high density cholesterol, TG-triglycerides.